BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30540967)

  • 1. Hemodynamic response to β-blockers in severe sepsis and septic shock: A review of current literature.
    van Loon LM; van der Hoeven JG; Lemson J
    J Crit Care; 2019 Apr; 50():138-143. PubMed ID: 30540967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blocker use in severe sepsis and septic shock: a systematic review.
    Sanfilippo F; Santonocito C; Morelli A; Foex P
    Curr Med Res Opin; 2015; 31(10):1817-25. PubMed ID: 26121122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is It Time to Beta Block the Septic Patient?
    Pemberton P; Veenith T; Snelson C; Whitehouse T
    Biomed Res Int; 2015; 2015():424308. PubMed ID: 26557668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers in septic shock: a review.
    Vela-Vásquez RS; Grigorov-Tzenkov I; Aguilar JL
    Rev Esp Anestesiol Reanim; 2015 Feb; 62(2):90-5. PubMed ID: 25152109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of β-adrenergic blockade therapy on septic shock and sepsis: A systematic review and meta-analysis of randomized controlled studies.
    Li J; Sun W; Guo Y; Ren Y; Li Y; Yang Z
    Cytokine; 2020 Feb; 126():154916. PubMed ID: 31756644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-blockers in Septic Shock].
    Uhlig C; Spieth PM
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Nov; 53(11-12):787-792. PubMed ID: 30458576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of the β-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study].
    Yang S; Liu Z; Yang W; Zhang G; Hou B; Liu J; Shi Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct; 26(10):714-7. PubMed ID: 25315942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepsis and beta-blockade: a look into diastolic function.
    Astuto M
    Curr Med Res Opin; 2015; 31(10):1827-8. PubMed ID: 26211819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new frontier for an old drug? A word of caution for beta-blockers in sepsis!
    Maybauer MO; Maybauer DM
    Curr Med Res Opin; 2015; 31(10):1829-30. PubMed ID: 26296157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of Beta-Blockade in Sepsis and Septic Shock: A Systematic Review.
    Lee YR; Seth MS; Soney D; Dai H
    Clin Drug Investig; 2019 May; 39(5):429-440. PubMed ID: 30848423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.
    Unger M; Morelli A; Singer M; Radermacher P; Rehberg S; Trimmel H; Joannidis M; Heinz G; Cerny V; Dostál P; Siebers C; Guarracino F; Pratesi F; Biancofiore G; Girardis M; Kadlecova P; Bouvet O; Zörer M; Grohmann-Izay B; Krejcy K; Klade C; Krumpl G
    Trials; 2018 Nov; 19(1):637. PubMed ID: 30454042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term β-Blocker Therapy Decreases Blood Lactate Concentration in Severely Septic Patients.
    Contenti J; Occelli C; Corraze H; Lemoël F; Levraut J
    Crit Care Med; 2015 Dec; 43(12):2616-22. PubMed ID: 26427590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of steroids in the treatment of severe sepsis and septic shock.
    Batzofin BM; Sprung CL; Weiss YG
    Best Pract Res Clin Endocrinol Metab; 2011 Oct; 25(5):735-43. PubMed ID: 21925074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
    Morelli A; Ertmer C; Westphal M; Rehberg S; Kampmeier T; Ligges S; Orecchioni A; D'Egidio A; D'Ippoliti F; Raffone C; Venditti M; Guarracino F; Girardis M; Tritapepe L; Pietropaoli P; Mebazaa A; Singer M
    JAMA; 2013 Oct; 310(16):1683-91. PubMed ID: 24108526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta-blockers in septic patients.
    Hamzaoui O; Teboul JL
    Minerva Anestesiol; 2015 Mar; 81(3):312-9. PubMed ID: 24941896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers in intensive care medicine: potential benefit in acute brain injury and acute respiratory distress syndrome.
    van der Jagt M; Miranda DR
    Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):141-51. PubMed ID: 22642505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines.
    Silverman HJ; Penaranda R; Orens JB; Lee NH
    Crit Care Med; 1993 Jan; 21(1):31-9. PubMed ID: 8380553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin replacement in patients with sepsis and septic shock.
    Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
    Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short term effects of hypertonic saline during severe sepsis and septic shock].
    Muller L; Lefrant JY; Jaber S; Louart G; Mahamat A; Ripart J; de La Coussaye JE; Eledjam JJ
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):575-80. PubMed ID: 15234722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of β-blockers on mortality in patients with sepsis: A propensity-score matched analysis.
    Ge CL; Zhang LN; Ai YH; Chen W; Ye ZW; Zou Y; Peng QY
    Front Cell Infect Microbiol; 2023; 13():1121444. PubMed ID: 37056709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.